AIMMUNE THERAPEUTICS INC's ticker is AIMT and the CUSIP is 00900T107. A total of 132 filers reported holding AIMMUNE THERAPEUTICS INC in Q4 2018. The put-call ratio across all filers is 0.62 and the average weighting 0.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2020 | $3,313,000 | +113.7% | 96,174 | +3.7% | 0.00% | +200.0% |
| Q2 2020 | $1,550,000 | +46.0% | 92,774 | +25.9% | 0.00% | 0.0% |
| Q1 2020 | $1,062,000 | -55.9% | 73,674 | +2.5% | 0.00% | -50.0% |
| Q4 2019 | $2,406,000 | +65.4% | 71,874 | +3.5% | 0.00% | 0.0% |
| Q3 2019 | $1,455,000 | +0.6% | 69,474 | 0.0% | 0.00% | 0.0% |
| Q2 2019 | $1,446,000 | -11.8% | 69,474 | -5.3% | 0.00% | 0.0% |
| Q1 2019 | $1,640,000 | +2.1% | 73,374 | +9.2% | 0.00% | 0.0% |
| Q4 2018 | $1,607,000 | -8.6% | 67,174 | +4.2% | 0.00% | 0.0% |
| Q3 2018 | $1,759,000 | +1.4% | 64,474 | 0.0% | 0.00% | 0.0% |
| Q2 2018 | $1,734,000 | -15.5% | 64,474 | 0.0% | 0.00% | -33.3% |
| Q1 2018 | $2,052,000 | +33.7% | 64,474 | +58.9% | 0.00% | +50.0% |
| Q4 2017 | $1,535,000 | +67.4% | 40,574 | +9.7% | 0.00% | +100.0% |
| Q3 2017 | $917,000 | +20.7% | 36,974 | 0.0% | 0.00% | 0.0% |
| Q2 2017 | $760,000 | -5.4% | 36,974 | 0.0% | 0.00% | 0.0% |
| Q1 2017 | $803,000 | +24.7% | 36,974 | +17.5% | 0.00% | 0.0% |
| Q4 2016 | $644,000 | +36.4% | 31,474 | 0.0% | 0.00% | 0.0% |
| Q3 2016 | $472,000 | +38.4% | 31,474 | 0.0% | 0.00% | 0.0% |
| Q2 2016 | $341,000 | +16.8% | 31,474 | +41.3% | 0.00% | 0.0% |
| Q1 2016 | $292,000 | +19.2% | 22,274 | +67.5% | 0.00% | 0.0% |
| Q4 2015 | $245,000 | – | 13,300 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Foresite Capital Management II, LLC | 3,300,797 | $90,046,000 | 33.32% |
| Aisling Capital LLC | 1,990,000 | $54,287,000 | 11.73% |
| Foresite Capital Management III, LLC | 801,240 | $21,858,000 | 4.82% |
| PACIFIC VIEW ASSET MANAGEMENT, LLC | 189,857 | $5,181,000 | 4.12% |
| AlpInvest Partners B.V. | 38,943 | $1,062,000 | 2.27% |
| Eventide Asset Management | 1,739,000 | $47,440,000 | 1.74% |
| Palo Alto Investors LP | 1,381,759 | $37,694,000 | 1.52% |
| Sofinnova Investments, Inc. | 222,295 | $6,064,000 | 0.54% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 553,000 | $15,086,000 | 0.54% |
| EMERALD ADVISERS, LLC | 486,666 | $13,276,000 | 0.49% |